Meningococcal disease in Los Angeles County, California, and among men in the county jails

New England Journal of Medicine

Volumn 335, Issue 12, 1996, Pages 833-840

  Tappero, Jordan W ^a   Reporter, Roshan ^c   Wenger, Jay D ^a   Ward, Bridget A ^c   Reeves, Michael W ^a   Missbach, Timm S ^a   Plikaytis, Brian D ^b   Mascola, Laurene ^c   Schuchat, Anne ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE CARRIER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PRIORITY JOURNAL; PRISON; SEROTYPING; THROAT CULTURE;

CARRIER STATE; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; INCIDENCE; LOS ANGELES; MALE; MENINGOCOCCAL INFECTIONS; MULTIVARIATE ANALYSIS; NEISSERIA MENINGITIDIS; PHARYNX; PRISONERS; PRISONS; RISK FACTORS;

EID: 0029786497     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609193351201     Document Type: Article

References (52)

1. King L, Geis G. Tuberculosis transmission in a large urban jail. JAMA 1977;237:791-2.
2. Stead WW. Undetected tuberculosis in prison: source of infection for community at large. JAMA 1978;240:2544-7.
3. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994; 170:151-6.
4. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR Morb Mortal Wkly Rep 1992;41:507-9.
5. Tuberculosis transmission in a state correctional institution - California, 1990-1991. MMWR Morb Mortal Wkly Rep 1992;41:927-9.
6. Hospedales CJ, Johnson D, Hall W, Stobierski M, Hutchinson C, Dietrich S. Outbreak of Legionnaires' disease associated with a cooling tower at a state prison, Michigan. In: Epidemic Intelligence Service: 43rd annual conference. Atlanta: Centers for Disease Control and Prevention, 1994.
7. Hoge CW, Rcichlcr MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994;331:643-8.
8. Rubella outbreaks in prisons - New York City, West Virginia, California. MMWR Morb Mortal Wkly Rep 1989;34:615-8.
9. Varicella outbreak in a women's prison - Kentucky. MMWR Morb Mortal Wkly Rep 1989;38:635-6, 641-2.
10. Thomas JC, Bendana NS, Waterman SH, et al. Risk factors for carriage of meningococcus in the Los Angeles County men's jail system. Am J Epidemiol 1991;133:286-95.
11. Thomas JC, Bendana NS, Waterman SH. Meningococcal disease in Los Angeles County, 1981 through 1990. Am J Public Health 1993;83:1790-1.
12. Caugant DA, Mocca LF, Frasch CE, Froholm LO, Zollinger WD, Selander RK. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 1987;169:2781-92.
13. Woods TC, Helsel LO, Swaminathan B, et al. Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping). J Clin Microbiol 1992;30:132-7.
14. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986;51: 873-84.
15. Jacobs D. SAS/GRAPH software and numerical taxonomy. In: Proceedings of 15th Annual SAS Users Group Conference, Nashville, April 1-4, 1990. Cary, N.C.: SAS Institute, 1990:1413-8.
16. Microsoft Windows environment: changes and enhancements to the SAS system, release 6.10. Cary, N.C.: SAS Institute, 1994.
17. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986;18:Suppl A:25-34.
18. Schwartz B. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections. Rev Infect Dis 1991;13:Suppl 2:S170-S173.
19. Meningococcal Disease Study Group. Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976;235:261-5.
20. De Wals P, Hertoghe L, Borlee-Grimee I, et al. Meningococcal disease in Belgium: secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect 1981;3:Suppl:53-61.
21. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA 1995;273:383-9.
22. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect 1994;112:315-28.
23. Stuart JM, Cartwright KAV, Dawson JA, Rickard J, Noah ND. Risk factors for meningococcal disease: a case control study in south west England. Community Med 1988;10:139-46.
24. Jones DM, Kaczmarski EB. Meningococcal infections in England and Wales: 1993. Commun Dis Rep CDR Rev 1994;4(9):R97-R100.
25. Harrison LH, Armstrong CW, Jenkins SR, et al. A cluster of meningococcal disease on a school bus following epidemic influenza. Arch Intern Med 1991;151:1005-9.
26. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, Palmer SR. Influenza A and meningococcal disease. Lancet 1991;338:554-7.
27. Moore PS, Hierholzer J, DeWitt W, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990;264:1271-5.
28. Morrow HW, Slaten DD, Reingold AL, Werner SB, Fenstersheib MD. Risk factors associated with a school-related outbreak of serogroup C meningococcal disease. Pediatr Infect Dis J 1990;9:394-8.
29. Krasinski K, Nelson JD, Butler S, Luby JP, Kusmiesz H. Possible association of mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol 1987;125:499-508.
30. Young LS, LaForce FM, Head JJ, Feeley JC, Bennett JV. A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 1972;287:5-9.
31. Haneberg B, Tønjum T, Rodahl K, Gedde-Dahl TW. Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, stressful events, physical fitness and general symptoms of ill health. NIPH Ann 1983;6:169-73.
32. Imrey PB, Jackson LA, Ludwinski PH, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol 1996;143:624-30.
33. Idem. Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak. J Clin Microbiol 1995;33:3133-7.
34. Le Saux N, Ashton F, Rahman M, et al. Carriage of Neisseria species in communities with different rates of meningococcal disease. Can J Infect Dis 1992;3:60-4.
35. Mitchell LA, Ochnio JJ, Glover C, Lee AY, Ho MK-L, Bell A. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents. J Infect Dis 1996;173:1009-13.
36. Greenfield S, Sheehe PR, Feldman HA. Meningococcal carriage in a population of "normal" families. J Infect Dis 1971;123:67-73.
37. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococccus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307-26.
38. Munford RS, Taunay AE, de Morais JS, Fraser DW, Feldman RA. Spread of meningococcal infection within households. Lancet 1974;1:1275-8.
39. Caugant DA, Høiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994;32:323-30.
40. Olsen SF, Djurhuus B, Rasmussen K, et al. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 1991;106:445-57.
41. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M, Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978;137:112-21.
42. Marks MI, Frasch CE, Shapera RM. Meningococcal colonization and infection in children and their household contacts. Am J Epidemiol 1979; 109:563-71.
43. Aycock WL, Mueller JH. Meningococcus carrier rates and meningitis incidence. Bacteriol Rev 1950;14:115-60.
44. Fraser PK, Bailey GK, Abbott JD, Gill JB, Walker DJ. The meningococcal carrier-rate. Lancet 1973;1:1235-7.
45. Kremastinou J, Blackwell C, Tzanakaki G, Kallergi C, Elton R, Weir D. Parental smoking and carriage of Neisseria meningitidis among Greek schoolchildren. Scand J Infect Dis 1994;26:719-23.
46. Stuart JM, Cartwright KAV, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet 1989;2:723-5.
47. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: emergence of a virulent clone of Neisseria meningitidis. JAMA 1995;273:390-4.
48. Scholten RJPM, Poolman JT, Valkenburg HA, Bijlmer HA, Dankert J, Caugant DA. Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in the Netherlands, 1958-1990. J Infect Dis 1994;169:673-6.
49. Serogroup B meningococcal disease - Oregon, 1994. MMWR Morb Mortal Wkly Rep 1995;44:121-4.
50. Reeves MW, Perkins BA, Diermayer M, Wenger JD. Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerging Infect Dis 1995;1:53-4.
51. Meningococcal vaccines. MMWR Morb Mortal Wkly Rep 1985;34: 255-9.
52. Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med 1993;118:139-45.